Phase IIISmall Molecule
Compound 61574
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061574
Risk Class
HIGH
Last Audit
Apr 17, 2108
Research Abstract
Small Molecule candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61574 is a small molecule asset inside small molecule innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase iii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061574 with updates logged 2108-04-17.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61574Small Molecule Program 61574
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061574
- [2] Operations Pulse • Small Molecule innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61574